EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations

Benedetta Russo, Giorgia D'Addato iD, Giulia Salvatore iD, Marika Menduni, Simona Frontoni iD, Luigi Carbone iD, Antonella Camaioni iD, Francesca Gioia Klinger iD, Massimo De Felici iD, Fabiana Picconi iD, Gina La Sala

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Benedetta Russo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Endocrinology and Diabetology, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy. Hauptthemen laut MEDLINE: Ependymoglial Cells, Glucose, Cellular Reprogramming. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Paolo Sbraccia, Department of Systems Medicine, University of Rome Tor Vergata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal neurodegeneration (RN), an early marker of diabetic retinopathy (DR), is closely associated with Müller glia cells (MGs) in diabetic subjects. MGs play a pivotal role in maintaining retinal homeostasis, integrity, and metabolic support and respond to diabetic stress. In lower vertebrates, MGs have a strong regenerative response and can completely repair the retina after injuries. However, this ability diminishes as organisms become more complex. The aim of this study was to investigate the gliotic response and reprogramming potential of the human Müller cell line MIO-M1 cultured in normoglycemic (5 mM glucose, NG) and hyperglycemic (25 mM glucose, HG) conditions and then exposed to sustained high-glucose and glucose fluctuation (GF) treatments to mimic the human diabetic conditions. The results showed that NG MIO-M1 cells exhibited a dynamic activation to sustained high-glucose and GF treatments by increasing GFAP and Vimentin expression together, indicative of gliotic response. Increased expression of SHH and SOX2 were also observed, foreshadowing reprogramming potential. Conversely, HG MIO-M1 cells showed increased levels of the indexes reported above and adaptation/desensitization to sustained high-glucose and GF treatments. These findings indicate that MIO-M1 cells exhibit a differential response under various glucose treatments, which is dependent on the metabolic environment. The in vitro model used in this study, based on a well-established cell line, enables the exploration of how these responses occur in a controlled, reproducible system and the identification of strategies to promote neurogenesis over neurodegeneration. These findings contribute to the understanding of MGs responses under diabetic conditions, which may have implications for future therapeutic approaches to diabetes-associated retinal neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ependymoglial CellsGlucoseCellular ReprogrammingHumansCell LineDiabetic RetinopathyVimentinSOXB1 Transcription FactorsGliosisGlial Fibrillary Acidic ProteinHedgehog Proteins

Stichwörter der Autor:innen

Müller cellsdedifferentiationdiabetesdiabetic retinopathyglucose fluctuationsprogenitor cellsretinal neurodegeneration

Substanzen

GlucoseVimentinSOXB1 Transcription FactorsGlial Fibrillary Acidic ProteinHedgehog ProteinsSHH protein, humanSOX2 protein, humanGFAP protein, human

Autor:innen und Institutionen

  • Unit of Endocrinology and Diabetology, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy.
  • Section of Histology and Embryology, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Unit of Emergency Room, Emergency Medicine and Internal Medicine, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy.
  • CNR Institute of Biochemistry and Cell Biology, 00015 Rome, Italy.

ORCID-Profile: Giorgia D'Addato, Giulia Salvatore, Simona Frontoni, Luigi Carbone, Antonella Camaioni, Francesca Gioia Klinger, Massimo De Felici, Fabiana Picconi

Förderung

  • Paolo Sbraccia
  • Department of Systems Medicine, University of Rome Tor Vergata

Zitieren

APA

Russo, B., D'Addato, G., Salvatore, G., Menduni, M., Frontoni, S., Carbone, L., Camaioni, A., Klinger, F. G., De Felici, M., Picconi, F., & La Sala, G. (2024). Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312877

Vancouver

Russo B, D'Addato G, Salvatore G, Menduni M, Frontoni S, Carbone L, et al. Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312877

BibTeX
@article{Russo2024,
  author = {Russo, Benedetta and D'Addato, Giorgia and Salvatore, Giulia and Menduni, Marika and Frontoni, Simona and Carbone, Luigi and Camaioni, Antonella and Klinger, Francesca Gioia and De Felici, Massimo and Picconi, Fabiana and La Sala, Gina},
  title = {Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312877}
}
Kostenlos starten →